Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers

For oral, oropharyngeal and oesophageal cancer, the early detection of tumours and of residual tumour after surgery are prognostic factors of recurrence rates and patient survival. Here, we report the validation, in animal models and a human, of the use of a previously described fluorescently labell...

Descripción completa

Detalles Bibliográficos
Autores principales: Kossatz, Susanne, Pirovano, Giacomo, De Souza França, Paula Demétrio, Strome, Arianna L., Sunny, Sumsum P., Zanoni, Daniella Karassawa, Mauguen, Audrey, Carney, Brandon, Brand, Christian, Shah, Veer, Ramanajinappa, Ravindra D., Hedne, Naveen, Birur, Praveen, Sihag, Smita, Ghossein, Ronald A., Gönen, Mithat, Strome, Marshall, Suresh, Amritha, Molena, Daniela, Ganly, Ian, Kuriakose, Moni A., Patel, Snehal G., Reiner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136849/
https://www.ncbi.nlm.nih.gov/pubmed/32165735
http://dx.doi.org/10.1038/s41551-020-0526-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136849/
https://www.ncbi.nlm.nih.gov/pubmed/32165735
http://dx.doi.org/10.1038/s41551-020-0526-9

Ejemplares similares